000 01048 a2200253 4500
005 20250517153442.0
264 0 _c20180522
008 201805s 0 0 eng d
022 _a1873-7560
024 7 _a10.1016/j.eururo.2017.04.030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMirtti, Tuomas
245 0 0 _aRe: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40.
_h[electronic resource]
260 _bEuropean urology
_c09 2017
300 _ae68-e69 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPrognosis
650 0 4 _aProstatic Neoplasms, Castration-Resistant
700 1 _aAittokallio, Tero
773 0 _tEuropean urology
_gvol. 72
_gno. 3
_gp. e68-e69
856 4 0 _uhttps://doi.org/10.1016/j.eururo.2017.04.030
_zAvailable from publisher's website
999 _c27168839
_d27168839